SUMMARY A prospective follow-up study was carried out to investigate the relation between smoking and risk of death after an acute myocardial infarction. The study consisted of male patients under the age of65 years, who had had an acute myocardial infarction between 1972 and 1975 in North Karelia, Finland. Of these patients, 888 survived the first six months after the acute infarction and were followed-up for three years after the infarction with regard to their deaths. The cumulative all-causes mortality rate of the patients who were still smoking six months after the acute myocardial infarction was 1-7 times that of the patients who had stopped smoking within the first six months. There was a dose-response relation between the number of cigarettes smoked daily and the mortality. The impact of smoking was greatest in the subgroups of patients with an otherwise good prognosis. We estimated that 28 per cent of the deaths in the whole group of initial smokers was attributable to continuing smoking after the infarction. On the basis of these findings we suggest that anti-smoking advice should be an important part of the modern comprehensive care of patients with an acute myocardial infarction.
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Some recent investigations show a lower mortality after an acute myocardial infarction in patients who stop smoking than in those who continue.1-3 There is also evidence that the lower mortality among the ex-smokers is not caused by other factors. In one earlier study the mortality in patients who stopped smoking did not differ from the mortality of those continuing smoking after infarction. 4 On the basis of the above-mentioned two studies with positive results on the relation between smoking and the prognosis after a myocardial infarction, it has frequently been suggested that antismoking measures after a myocardial infarction should be given a high priority when implementing secondary preventive intervention.
The purpose of the present study was to compare the risk of death after acute myocardial infarction in smokers who continued smoking with those who stopped, independent of other factors related to the risk of death, in a representative group of male patients with acute myocardial infarction under the age of 65, and in its risk-specific subgroups.
Subjects and methods
The study consisted of men under the age of 65 who were registered in the community myocardial Received for publication 13 August 1979 infarction register of North Karelia in Eastern Finland, which has some 180 000 inhabitants. The registered heart attacks are classified as 'definite' or 'possible' acute myocardial infarction, no infarction, or 'insufficient information' according to the rigid operational criteria that were used in the international co-operative myocardial infarction register study co-ordinated by the WHO.5 6 The diagnostic criteria and the methods of data collection of the register have been published previously in detail.7-9 Only patients with a 'definite' or 'possible' acute myocardial infarction, who survived the first six months after the infarction, were included in the study.
Information concerning the deaths and the causes of death of the subjects during the three-year period after the infarction was collected from death certificates.
The data on smoking and medical history before the infarction were gathered in an interview by a nurse as early as possible after the acute phase of the attack. The data connected with the course of the acute period and the diagnostic criteria were collected using a standard questionnaire. At The number of deaths between six months and three years after infarction among the patients giving up and those continuing to smoke is presented in Table 1 according to the cause of death.
Of the initial non-smokers, 52 (14 8 per 100, 95% confidence interval (CI) 11 1 to 18 5) died between six months and three years after the infarction. Among those giving up smoking after the infarction the number of deaths was 26 (11-8 per 100, CI 95% =7-5 to 16-0). Of the patients continuing to smoke after infarction 60 (19 9 per 100, CI 95% =15 4 to 24.4%) died between six months and three years after infarction.
The estimated crude all-causes death rate among the patients continuing to smoke after the infarction was thus 1-7 times that of those who stopped smoking (CI 95%=1 1 to 2 6, x2=5 52, p=0 019). The proportion of the deaths attributable to continuing smoking after infarction was 28 per cent (CI 95%=7 to 50%) or 24 (CI 95%=6 to 43) out of the 86 deaths in the whole group. When only the deaths between six and 12 months after the infarction are considered, the all-causes mortality rate ratio between smokers six months after the infarction and ex-smokers was 2 4 (CI 95% =1 0 to 6-0, x2 =4-06, p =0.044). The respective rate ratio for deaths between six months and two years after the infarction was 2-0 (CI 95% = 1.2 to 3 4, x2=6412, p=0-013).
In the subgroup of patients with a 'definite' acute myocardial infarction the ratio of death rates between six months and three years comparing current smokers and ex-smokers was 1-7 (CI 95%= 1-1 to 2.7, x2=4.73, p=0.030).
In the whole group, 82-6 per cent of all deaths were the result of ischaemic heart disease. The smoking-related ischaemic heart disease mortality rate ratio of smokers to ex-smokers did not reach statistical significance (p > 0 05) and did not differ significantly from the respective all-causes mortality rate ratio. The relative mortality for all cardiovascular diseases was 1-6 (CI 95%=10 to 2-6), and showed significance according to the test statistic (X2 =4X03, p =0 045) ( Table 1 ). In order to study the existence of a dose-response relation between smoking and mortality after acute myocardial infarction, we examined the cumulative all-causes mortality from six months to three years after infarction at different levels of smoking (Table 2) .
There was a trend for the rate ratio to increase with the number of cigarettes smoked daily.
In order to control the possible confounding effect of some factors expected to affect the mortality after acute myocardial infarction, all subjects were categorised first by age (Table 3 ) and, secondly, by history of previous acute myocardial infarction and/ or angina pectoris and occurrence of acute cardiac failure and/or cardiac arrest during the acute phase (Table 4) .
While the total mortality after acute myocardial infarction increased slightly with age, the death ratio related to smoking after infarction did not show any consistent trend by age. There was no significant difference in the age distributions of exsmokers and current smokers. For this reason no age adjustment is included in the analysis of the importance of other possible confounding factors. of other post-myocardial infarction risk fac The smoking-related death rate ratio was in-( Table 5 ). The mortality of the smokers with significantly higher in the 'low-risk' subgroups, more than one of these risk factors was almost that is, in patients who had no other factors likely times higher than that of the patients who stop to contribute to high risk of death. Among patients smoking. There were more smokers than without previous acute myocardial infarction or smokers having at least four of the risk factors (1 angina pectoris and without acute heart failure or vs 110%). The adjusted summary rate ratio calcula cardiac arrest in the acute phase, the estimate of over the four strata was 1 6 and still statistic the rate ratio was 2A4 but did not deviate significantly significant (Mantel-Haenszel x2 with 1 df =3 from unity (Table 4) . Previous acute myocardial p =0.035). infarction or angina pectoris was more prevalent among smokers than among non-smokers (69% vs Discussion 65%). The smoking-related mortality rate ratio was also calculated according to the number of The purpose of the study was to investigate some selected factors contributing to mortality. relation between stopping smoking and long-t These factors were age, diagnostic category of mortality after acute myocardial infarction, c infarction, history of previous acute myocardial sidering simultaneously some of the other fac infarction, prodromal or previous angina pectoris, contributing to this mortality and examining acute heart failure at the onset of attack, or during relation in subgroups of patients with different r the hospital treatment, and cardiac arrest during the of death. the hospital treatment (Table 5) .
For the study we chose all male patients uni There was a slight downward trend in the the age of 65, who had suffered a definite c smoking-related rate ratio with increasing number possible acute myocardial infarction according the North Karelia community myocardial infarction register, and who had survived the first six months after the onset of symptoms. The patients were from a complete unselected four-year series of men under 65 years of age with myocardial infarction who were detected in a geographically and administratively defined population. The diagnostic validity of the registration has been considered earlier, based on a blind reclassification into the defined diagnostic categories of a sample of the registered heart attacks.9 The coverage of the registration is being cross-checked against the national hospital discharge data.
The patients dying within the first six months after the infarction were not included in the study because the data concerning change in smoking habit were not available earlier than six months after the infarction. This resulted in a reduction of the study population but also decreased the possible confounding effect of infarct size and severity of infarction on the relation between smoking and mortality.
The data on smoking were almost complete though reliance had to be placed on a mailed questionnaire. The relation of smoking to mortality was studied solely on the basis of the deaths occurring after the measurement of smoking, and the smoking status during the follow-up of 'outcome events' (deaths) was not taken into account in the analysis, so that any bias caused by the selective missing data concerning smoking because of deaths could be avoided. It also follows, however, from the design that there might have been some 'drop-out' and 'drop-in' of smokers into the 'reference group', that is, ex-smokers and vice versa. It is likely that some smokers stopped smoking six months after the infarction, and some of those who had stopped smoking before six months started again afterwards. This assumption is supported by the finding that the mortality ratio between smokers and ex-smokers was higher when shorter periods of follow-up were considered. The contamination between the exposed and the nonexposed-the random error in the measurement of exposure-would have caused underestimation of the rate ratios.
The ratio of the mortality rate of smokers to that of ex-smokers was used as an estimator of relative risk, a measurement of the strength of the relation between smoking and survival. This was possible because of the prospective nature of the study. The use of the odds ratio (cross-product ratio) as an estimator of relative risk was considered improper because of the relatively high rate of outcome events, which exceeded the limit of 10 per cent that has been suggested as the maximum to make the approximation possible.'5 The use of the odds ratio, as has been done in some studies with a similar design would probably have resulted in an overestimation of relative risks. In addition, the measure of statistical significance, x2 with the correction for continuity, is a conservative test statistic and leads to two-sided testing of the relation studied. It is possible that the design of the study and the statistical analysis of the data produce a bias towards accepting the null hypothesis rather than rejecting it. If smoking status after infarction had been defined in another way, its relation to mortality after infarction would probably have seemed closer.
Summary x2 statistics were used as presented by Mantel and Haenszel,14 in which the weights for the strata of the covariate are given partly on the basis of their relative importance and partly to minimise the variance. According to the authors, the use of this summary statistic does not require the assumption of homogeneity of rate ratio over the strata to be combined. The use of the MantelHaenszel rate ratio statistic has been recommended as a combined estimator of the odds ratio, when the number of strata is more than two. '8 In the whole group of initial smokers the total mortality between six months and three years after the infarction was 1-7 times and respective mortality from ischaemic heart disease was 1-6 times higher in the patients who continued to smoke than in those who gave up smoking within six months of infarction. The total mortality rate ratio was exactly the same in patients registered as having a definite acute myocardial infarction according to the defined rigid operational criteria.
It was found that the all-causes mortality in those giving up smoking was somewhat lower than that in initial non-smokers. This could be explained in two ways. Firstly, it is likely that initial smokers had a higher early mortality than non-smokers, as suggested by some previous studies.8 17 Therefore there might have been more patients with a severe course of infarction in the acute period who remained among the initial non-smokers. Secondly, those who did not smoke before the infarction must, on average, have had some factors other than smoking which increased the risk of infarction and probably also later the risk of death.
The strength of the relation between smoking and risk of death after acute myocardial infarction seemed to be increased in the subgroups of patients with a lower risk according to other factors contributing to post-myocardial infarction mortality. According to these data, the impact of smoking after acute myocardial infarction is almost twice as great among patients without a previous infarction or angina pectoris, and more than two-thirds greater among those without acute heart failure or cardiac arrest during the acute period of infarction, as compared with the others. The results of the analysis where seven important predictors of death after infarction were taken into account, also support the finding that continuing smoking after acute myocardial infarction is related to the greatest extra risk of death in the patients who otherwise would have had a good prognosis in terms of survival.
Among 405 male patients with a first myocardial infarction, aged 67 and below, who were registered in the Gothenburg myocardial infarction register, the patients who continued to smoke had a 1-9 times greater all-causes two-year mortality after infarction than those who had stopped smoking within three months of the infarction.' In the series of 190 patients with a first attack of acute coronary insufficiency or myocardial infarction, aged under 60, who were admitted to the cardiac department at St. Vincent's Hospital, Dublin, and who had survived 28 days or longer, the respective cumulative five-year mortality rate ratio was 1 6. The mortality of the patients who did not reduce their smoking (or did so by less than 50%) was twice as high as those who stopped or reduced smoking by at least 50 per cent (calculated on the basis of the figures given in Table 33 ). The strength of the relation in these two previous studies is of the same magnitude as that observed in the present study.
In the latter study, the relation of smoking to mortality after the infarction was also considered separately in the group of patients with acute coronary insufficiency or an 'uncomplicated' myocardial infarction andwith a'complicated'myocardial infarction. The rate ratios in these two subgroups between smokers and those who stopped or reduced were 1A4 and 4 0 (Table 4) .3 Though not significant, this finding is not in agreement with the present study finding that smoking might have its greatest importance among patients with acute myocardial infarction without 'complications'. The lack of agreement could be caused by the small number of deaths in the Irish study, resulting in a large sampling variation, and by the difference in the selection of 'complications' that were taken into consideration.
In the present study there was a direct, statistically significant overall association between smoking and long-term prognosis after an acute myocardial infarction and a clear dose-response relation. In addition, the measurement of smoking preceded the observation of mortality, and the association remained significant, when the effect of some of the most important confounding factors was removed. So, assuming that there were no other extraneous factors producing a pseudoassociation, the association could be considered as a causal one, the mechanisms of which remain to be explained.
Because of the representativeness of the material the results seem to be applicable to any infarction patient population with similar characteristics. The existence of a common causal relation is supported by earlier similar findings. It is probable that the relation is strongest among patients with an otherwise good prognosis.
On the basis of our findings we estimated that among patients who had smoked before the infarction, 28 per cent, or 24 out of the 86 deaths, were attributable to continuing to smoke after the infarction and thus could, theoretically, have been prevented for three years at least by complete control of smoking after the infarction. For the reason that smoking seems to be one of the few things affecting the prognosis after an acute myocardial infarction which can be modified permanently and without any side effects, antismoking advice should be an essential part of the modem comprehensive care of these patients.
Our findings suggest that an individual patient who had smoked before the infarction could reduce his risk of dying during the next years by one-third by giving up smoking after the infarction. This information could be useful in motivating the patients with an acute myocardial infarction to stop smoking.
Because of the considerable prognostic impact of smoking, further studies on the methods of antismoking health education among the patients with an acute myocardial infarction are needed. 
